Ca2+ and CaMKII cascade contribute to MPF inactivation and premature MAPK decline. Ca2+-free medium, Ca2+ chelator, Ca2+ channel blockers, NCX1 activator, and CaMKII inhibitors have been applied, but these methods cannot fully block OSA or can cause obvious side effects. This evidence concerns the gene SLC8A1 and obstructive sleep apnea syndrome.